San Francisco, CA - The Diagnostic Systems Group of Olympus America Inc. and Dade Behring Inc., manufacturer of Syva EMIT® drugs of abuse (DAT) and therapeutic drug monitoring (TDM) products, announced today that they have finalized terms on agreements that create U.S. sales, marketing and distribution relationships.
The first agreement allows Dade Behring to sell Olympus analytical systems to the high-volume toxicology laboratories in the U.S. Dade Behring now can better meet the needs of these specialized laboratories by offering its highest quality reagents on the Olympus platform, which provides maximum throughput and optimal workflow. Olympus can sell directly to select high-volume customers and non-Syva accounts.
In addition, Olympus has secured an exclusive agreement with Dade Behring to distribute the Syva® Emit® II Plus liquid DAT reagents and Emit® 2000 liquid TDM reagents in uniquely packaged Olympus cassettes to all hospitals and laboratories in the U.S. that use Olympus analyzers. Both Olympus and Dade Behring will be able to sell to their respective customers Syva® EMIT® reagents for TDMs and DATs in convenient, bar-coded Olympus cassettes.
"We are delighted to be associated with Olympus, a company well-known for the quality of its systems," said Hiroshi Uchida, president, Americas and Asia Pacific for Dade Behring. "We believe that laboratorians at high-volume DAT facilities will be the primary beneficiaries of this relationship. They will be able to work with their current Syva Company or Olympus Diagnostics Systems representatives to learn about the superior product benefits that each firm has to offer."
"Olympus is very excited about offering our customers additional convenience and ease of use with this new combination of Syva and Olympus products," said Stephen Wasserman, group vice president, Diagnostics Systems Group of Olympus. "Now hospitals and toxicology labs will have the best of both worlds - ready access to premier Syva® EMIT® reagents conveniently packaged and our broad line of cost-effective systems."
During the American Association for Clinical Chemistry (AACC) annual meeting here in San Francisco Olympus exhibited its complete line of chemistry immuno systems in its own booth, and an Olympus AU640TM analyzer was displayed at Dade Behring's exhibit.
For more information about the new packaging and Olympus chemistry immuno systems, please call the Diagnostic Systems Group 1-800-223-0125, or visit the Olympus web site at www.olympus.com.
About Olympus America Inc.
Olympus America Inc. distributes a wide range of products that leverage its core expertise in optics and digital information technology for the consumer, scientific, health care, commercial and industrial markets. These products include film and filmless cameras, microcassette and digital voice recorders, binoculars, film scanners, personal photo printers, medical and industrial endoscopes, biological and metallurgical microscopes and measuring instruments, clinical diagnostic analyzers, and high-technology products. Olympus America Inc. is responsible for sales, marketing, and distribution in the U.S., Canada, Mexico, the Caribbean, and Central and South America. Located in Melville, NY, Olympus America Inc. is a subsidiary of Olympus Optical Co., Ltd. with worldwide revenues of $3.8 billion for the fiscal year 2000.
About Syva Company
Syva, a wholly owned subsidiary of Dade Behring Inc., is the leader in the drugs-of-abuse testing market. Syva serves clinical as well as non-clinical markets such as criminal justice, occupational health, and on-site workplace testing.
About Dade Behring
With 1999 revenues of $1.3 billion, Dade Behring is among the largest clinical diagnostics companies worldwide, making it today's best resource by offering a wide range of products and systems for diagnostics testing. The company is headquartered in Deerfield, Illinois, and has operations in 40 countries. Additional company information can be found on the Internet at www.dadebehring.com.